Roche's Emicizumab Progresses Against Hemophilia's Next Big Challenge: Patients With Factor VIII Inhibitors

 
• By John Davis
Coagulation Factor VIII Protein
Coagulation Factor VIII Protein • Source: Shutterstock

More from Clinical Trials

More from R&D